ArticleBMC microbiology2025
Characteristics of compensatory mutations in rifampicin-resistant tuberculosis and their association with compensated transmission in Ningbo, China.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Analysis of Drug Resistance Characteristics and Risk Factors of Cavitary Tuberculosis Based on Whole Genome Sequencing and Machine Learning.Open forum infectious diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThe global spread of rifampicin-resistant tuberculosis (RR-TB) presents a significant challenge to tuberculosis control, with compensatory mutations hypothesized to offset the fitness cost of drug resistance, thereby facilitating transmission. However, the characteristics and epidemiological impact of these mutations in coastal regions of Eastern China remain inadequately understood. This study aimed to characterize the spectrum of compensatory mutations in RR-TB isolates and to assess their association with transmission dynamics in a well-developed coastal region of Eastern China.
methodsWe collected RR-TB cases identified through drug-resistance surveillance in Ningbo, China, from 2021 to 2024. Whole-genome sequencing (WGS) was performed on 180 RR-TB isolates to identify resistance-conferring and compensatory mutations, particularly in the rpoA, rpoB, and rpoC genes. Transmission clusters were inferred using single nucleotide polymorphism (SNP) analysis, and the association between compensatory mutations and the risk of RR-TB clustering was evaluated using logistic regression.
resultsAmong the 180 RR-TB isolates analyzed, 28.9% harbored putative compensatory mutations, predominantly in rpoC. Isolates with compensatory mutations were significantly more likely to be part of genomic transmission clusters than those without such mutations (odds ratio: 4.28, 95% CI: 2.07-8.85). No significant differences in demographic or clinical characteristics were observed between clustered and non-clustered cases. Phylogenetic analysis indicated ongoing local transmission of compensated RR-TB strains.
conclusionCompensatory mutations are prevalent among RR-TB strains in coastal Eastern China and are strongly associated with increased transmission, underscoring their role in sustaining the RR-TB epidemic in this region. Enhanced molecular surveillance and targeted interventions are warranted to curb the spread of compensated RR-TB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.